Literature DB >> 15240813

Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity.

Jung-Kil Lee1, Ji-Eun Kim, Michael Sivula, Stephen M Strittmatter.   

Abstract

After ischemic stroke, partial recovery of function frequently occurs and may depend on the plasticity of axonal connections. Here, we examine whether blockade of the Nogo-NogoReceptor (NgR) pathway might enhance axonal sprouting and thereby recovery after focal brain infarction. Mutant mice lacking NgR or Nogo-AB recover complex motor function after stroke more completely than do control animals. After a stroke, greater numbers of axons emanating from the undamaged cortex cross the midline to innervate the contralateral red nucleus and the ipsilateral cervical spinal cord; this axonal plasticity is enhanced in ngr -/- or nogo-ab -/- mice. In rats with middle cerebral artery occlusion, both the recovery of motor skills and corticofugal axonal plasticity are promoted by intracerebroventricular administration of a function-blocking NgR fragment. Behavioral improvement occurs when therapy is initiated 1 week after arterial occlusion. Thus, delayed pharmacological blockade of the NgR promotes subacute stroke recovery by facilitating axonal plasticity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240813      PMCID: PMC6729662          DOI: 10.1523/JNEUROSCI.1643-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  62 in total

1.  A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord.

Authors:  D W Huang; L McKerracher; P E Braun; S David
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial.

Authors:  J H van der Lee; R C Wagenaar; G J Lankhorst; T W Vogelaar; W L Devillé; L M Bouter
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

3.  Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein.

Authors:  T GrandPré; F Nakamura; T Vartanian; S M Strittmatter
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

4.  Inhibitor of neurite outgrowth in humans.

Authors:  R Prinjha; S E Moore; M Vinson; S Blake; R Morrow; G Christie; D Michalovich; D L Simmons; F S Walsh
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

5.  Long-term functional end points following middle cerebral artery occlusion in the rat.

Authors:  T J Hudzik; A Borrelli; P Bialobok; D Widzowski; S Sydserff; A Howell; P Gendron; D Corbett; J Miller; G C Palmer
Journal:  Pharmacol Biochem Behav       Date:  2000-03       Impact factor: 3.533

6.  Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration.

Authors:  A E Fournier; T GrandPre; S M Strittmatter
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

7.  Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment.

Authors:  C Brösamle; A B Huber; M Fiedler; A Skerra; M E Schwab
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

8.  Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.

Authors:  M S Chen; A B Huber; M E van der Haar; M Frank; L Schnell; A A Spillmann; F Christ; M E Schwab
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

9.  A temporal MRI assessment of neuropathology after transient middle cerebral artery occlusion in the rat: correlations with behavior.

Authors:  D Virley; J S Beech; S C Smart; S C Williams; H Hodges; A J Hunter
Journal:  J Cereb Blood Flow Metab       Date:  2000-03       Impact factor: 6.200

10.  Functional assessments in mice and rats after focal stroke.

Authors:  A J Hunter; J Hatcher; D Virley; P Nelson; E Irving; S J Hadingham; A A Parsons
Journal:  Neuropharmacology       Date:  2000-03-03       Impact factor: 5.250

View more
  140 in total

1.  Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome.

Authors:  Amjad Shehadah; Jieli Chen; Xu Cui; Cynthia Roberts; Mei Lu; Michael Chopp
Journal:  J Neurol Sci       Date:  2010-05-07       Impact factor: 3.181

2.  Recovery from chronic spinal cord contusion after Nogo receptor intervention.

Authors:  Xingxing Wang; Philip Duffy; Aaron W McGee; Omar Hasan; Grahame Gould; Nathan Tu; Noam Y Harel; Yiyun Huang; Richard E Carson; David Weinzimmer; Jim Ropchan; Larry I Benowitz; William B J Cafferty; Stephen M Strittmatter
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

3.  Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.

Authors:  Xingxing Wang; Omar Hasan; Alexander Arzeno; Larry I Benowitz; William B J Cafferty; Stephen M Strittmatter
Journal:  Exp Neurol       Date:  2012-06-21       Impact factor: 5.330

Review 4.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

Review 5.  Targeting myelin to optimize plasticity of spared spinal axons.

Authors:  Angela L M Scott; Leanne M Ramer; Lesley J J Soril; Jacek M Kwiecien; Matt S Ramer
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

Review 6.  Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?

Authors:  Noam Y Harel; Stephen M Strittmatter
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

Review 7.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

Review 8.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

Review 9.  Targets for neural repair therapies after stroke.

Authors:  S Thomas Carmichael
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

10.  Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.

Authors:  Shih-Yen Tsai; Tiffanie M Markus; Ellen M Andrews; Joseph L Cheatwood; April J Emerick; Anis K Mir; Martin E Schwab; Gwendolyn L Kartje
Journal:  Exp Brain Res       Date:  2007-08-24       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.